| Date Filed | Type | Description |
| 06/15/2023 |
4
| Giles Lisa M. (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Granted 12,500 options to buy
@ $2.01, valued at
$25.1k
|
|
| 06/09/2023 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.86, valued at
$115.8k
|
|
| 08/11/2022 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $6.07, valued at
$182.1k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2021 |
4
| Giles Lisa M. (Director) has filed a Form 4 on HCW Biologics Inc.|
Txns:
| Granted 37,037 options
@ $2.7, valued at
$100k
|
|
| 10/28/2021 |
3
| Giles Lisa M. (Director) has filed a Form 3 on HCW Biologics Inc. |
| 07/29/2021 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.54, valued at
$166.2k
|
|
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 30,000 options to buy
@ $7.1, valued at
$213k
|
|
| 10/05/2020 |
3
| Giles Lisa M. (Director) has filed a Form 3 on Milestone Pharmaceuticals Inc. |
| 06/02/2020 |
4
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 13,825 shares
@ $0 |
|
| 11/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 17,937 shares
@ $0 |
|
| 05/29/2018 |
4
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 17,107 shares
@ $0 |
|
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/22/2016 |
4/A
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Bought 177 shares
@ $9.4, valued at
$1.7k
|
|
| 08/16/2016 |
4
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Bought 823 shares
@ $9.4, valued at
$7.7k
|
|
| 05/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/04/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2015 |
4
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 6,483 shares
@ $0 |
|
| 02/23/2015 |
4
| Giles Lisa M. (Director) has filed a Form 4 on GenMark Diagnostics, Inc.|
Txns:
| Granted 1,730 shares
@ $0
Granted 19,062 options to buy
@ $13.17, valued at
$251k
|
|
| 11/19/2014 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 2,500 shares
@ $0
Disposed/sold 6,250 options to buy
@ $9.38, valued at
$58.6k
Disposed/sold 1,875 options to buy
@ $7.16, valued at
$13.4k
Disposed/sold 11,145 options to buy
@ $7.16, valued at
$79.8k
Disposed/sold 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
| 05/22/2014 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Granted 8,575 options to buy
@ $16.15, valued at
$138.5k
|
|
| 01/23/2014 |
4
| Giles Lisa M. (Director) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $8.25, valued at
$4.1k
|
|
| 12/03/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |